readthroughSign in
CompanyPPCBNasdaqCamberwell, Victoria, C3

Propanc Biopharma, Inc.

Propanc Biopharma develops pancreatic proenzyme therapies targeting cancer stem cells.

10-QNov 13Latest SEC filing
Oct 29Latest story